✦ LIBER ✦

Enhanced surveillance of hepatitis B in Canada, 1999–2004: Implication for immunization policy

✍ Scribed by J. Wu; H.X. Wu; A. Andonov; A. Giulivi

Book ID: 116224876
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 44 KB
Volume: 15
Category: Article
ISSN: 1047-2797
DOI: 10.1016/j.annepidem.2005.07.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

647 ENHANCED HEPATITIS STRAIN SURVEILLAN

647 ENHANCED HEPATITIS STRAIN SURVEILLANCE SYSTEM (EHSSS) IN CANADA: ANALYSIS OF HEPATITIS B RISK FACTOR DATA FROM 1999–2006

✍ A. Dudani; H.X. Wu; Q. Li; A. Andonov; J. Wu 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Analysis of a pregnancy-screening and ne

Analysis of a pregnancy-screening and neonatal-immunization program for hepatitis B in Hamilton, Ontario, Canada, 1977-1988

✍ Dr. Max A. Chernesky; Morris A. Blajchman; Santina Castriciano; Judy Basbaum; Ch 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB

## Abstract During the 12 years from January, 1977, to December, 1988, the Hamilton Centre of the Canadian Red Cross Society (CRCS) Blood Transfusion Service screened 98,712 pregnant patients for hepatitis B surface antigen (HBsAg) and identified 120 positives (0.12%). The number of positives range

Prevalence of hepatitis A virus and hepa

Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: implications for vaccination strategy

✍ Firdous Siddiqui; Milton Mutchnick; Joseph Kinzie; Rene Peleman; Paul Naylor; Mu 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 193 KB

Incidence and routes of transmission of

Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995–2000: implications for immunisation policy

✍ Susan Hahné; Mary Ramsay; Koye Balogun; W.John Edmunds; Philip Mortimer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 400 KB

Misleading hepatitis B test results due

Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia

✍ Donald M. Arnold; Mark A. Crowther; Ralph M. Meyer; Julie Carruthers; Julie DiTo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Incidence and risk factors for newly acq

Incidence and risk factors for newly acquired hepatitis C virus infection among Aboriginal versus non-Aboriginal Canadians in six regions, 1999–2004

✍ H.-X. Wu; J. Wu; T. Wong; A. Andonov; Q. Li; K. Dinner; T. Donaldson; S. Paton; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 180 KB